Population and Public Health

Can the $50 Billion Fund Save Rural Healthcare?
Care Can the $50 Billion Fund Save Rural Healthcare?

The Rural Health Transformation Program (RHTP) represents a historic pivot in how the federal government approaches the sustainability of care in sparsely populated regions. Established as a cornerstone of the 2025 budget reconciliation framework, the program emerged from the legislative package

Can Generic Ozempic Improve Diabetes Care in Canada?
Care Can Generic Ozempic Improve Diabetes Care in Canada?

The Evolving Landscape of Metabolic Treatment in Canada The landscape of Canadian metabolic health is undergoing a profound transformation as the first generic version of semaglutide enters a market previously dominated by high-cost branded medications. For several years, the reliance on expensive

How Can We Rebalance the Global Health Data Economy?
Data and Information How Can We Rebalance the Global Health Data Economy?

The existing global health data economy is currently built upon a precarious foundation where the immense costs of capturing medical information are borne by clinical systems while the financial rewards are largely harvested by external technology giants. This structural value asymmetry creates a

Medically Tailored Meals Face Uncertainty Amid Medicaid Cuts
Care Medically Tailored Meals Face Uncertainty Amid Medicaid Cuts

Within the stainless-steel corridors of specialized kitchens across the nation, the clatter of pans and the scent of fresh vegetables signify something far more profound than a mere meal service; these are clinical laboratories where nutrition is treated as the primary defense against systemic

Chronic Illness in America: High Costs and Care Barriers
Care Chronic Illness in America: High Costs and Care Barriers

While the United States remains a global leader in biomedical innovation, a staggering number of citizens living with complex chronic illnesses are finding that the financial and administrative barriers to accessing that innovation are becoming increasingly insurmountable. This research summary

Will the FDA Approve Supervised Psychedelic Therapies?
Public Policy Will the FDA Approve Supervised Psychedelic Therapies?

Faisal Zain is a distinguished healthcare expert whose work at the intersection of medical technology and clinical diagnostics has helped redefine how we approach complex treatments. With a career dedicated to the manufacturing and implementation of advanced medical devices, he possesses a unique

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later